/index.php?option=com_iwpfile&file=/dir_01/he2002_1270.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_1269.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_1267.pdf


FDA ISSUES NATIONWIDE/INTERNATIONAL ALERT ON RECALLED OB/GYN AND SURGICAL DEVICES DUE TO HEALTH RISK



MQSRA Inspection Demonstration Program



on

March 14, 2002

Mr. Thomas Scully

Administrator

Centers for Medicare & Medicaid Services

200 Independence Ave. SW

Washington, D.C. 20201



/index.php?option=com_iwpfile&file=/dir_01/he2002_1263.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2002_1262.pdf


ud

M E M O R A N D U M

To: Reporters and editors

Fr: Jill Gerber, 202/224-6522

Re: health care fraud

Da: Thursday, March 14, 2002

Today at a Committee on Finance subcommittee hearing, Sen. Chuck Grassley, ranking member of the Finance Committee, asked Tom Scully, administrator of the Centers for Medicare and Medicaid Services, about the agency's workings with the Department of Justice on the Columbia HCA fraud case. Grassley made the following comment about the exchange.



gs

Statement of Senator Bob Graham, D-Florida

Finance Subcommittee on Health Care Hearing:

Reimbursement and Access to Prescription Drugs Under Medicare Part B

March 14, 2002

I'd like to thank the Chairman for holding this hearing, and for his longstanding leadership in the area of oral cancer drugs. I look forward to hearing from our witnesses, and expect an interesting morning.



Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.